ArticleNeurology and therapy2025

Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study.

Heinz Wiendl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.